NCT04809766 2025-04-20Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaFred Hutchinson Cancer CenterPhase 1 Terminated9 enrolled